FDA Inspection 1266335 — Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
The FDA completed an inspection of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. on Mar 14, 2025 in Nanjing. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 14, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nanjing (China)